Long-term survival of low- and intermediate risk TAVI-patients: a real world, single center comparison of 684 patients treated with the sapien 3 or the sapien XT device.
Amsterdam University Medical Centre, Amsterdam (Netherlands (The))
0
follower
10
more
presentations
in this session
Effect of transcatheter aortic valve implantation (TAVI) in acquired von Willebrand syndrome and molecular analysis of high-molecular-weight multimers.
Cardiac biomarkers and clinical scores for risk stratification in patients with severe symptomatic aortic stenosis undergoing TAVI. Which ranks first now?